Deutsche Being Bank Accused of Tax Fraud By Federal Prosecutors

Usa,Dollar,Money,Cash,,Real,Handcuffs,And,Judge,Gavel,On

The U.S. has been increasingly going after foreign financial institutions that try to skimp on taxes. The latest move from the IRS is an aggressive lawsuit against Deutsche Bank, which the federal tax agency claims owes the U.S. somewhere in the neighborhood of $190 million in overdue taxes, penalties and interest.

 However, if you ask Deutsche Bank, they settled this dispute five years ago. According to reports, the large German bank claims that it reached a settlement with the IRS back in 2009 and it is not sure why the U.S. is coming after again regarding the same taxes.

 The issue revolves around a deal that began back in 200 when Deutsche Bank acquired a company that owned three million shares of Bristol-Myers Squibb. When those shares jumped in value, the U.S. claims that Deutsch Bank skipped out on tens of millions of dollars in taxes from capital gains, when the bank eventually sold the shares.

 According to the lawsuit the U.S. claims that the bank set up several so-called “shell companies” in order to absorb the tax blow from the profits made when they sold the shares. The IRS claims, however, that those shell companies did not have enough money to pay the taxes the federal government was owed. The lead prosecutor in the case claims that Deutsche Bank was involved in “nothing more than a shell game.”

Posted in ,
Bob Bennett

Hope For America | Bob Bennett

  About Bob Bennett Former Senator Bob Bennett is the chairman of Bennett Group International, a private business and governmental consulting group he founded after leaving government service in 2011. As a U.S. Senator from Utah, he was a senior member of the Senate Banking Committee and a member of the distinguished Joint Economic Committee.…

Are You Ready For Retirement? | Jason Greenwood

  About Jason Greenwood In 1999 Jason started his career in the financial services industry. While at Fidelity Investments he learned the importance of diversification and how to trade effectively. As an options trader for Client Services he became adept in the stock and derivatives markets. Desiring to become more involved with clients portfolios, Jason…

Dr. Benjamin Chen; The Science of Immunology

The Science of Immunology | Dr. Benjamin Chen

  About Dr. Benjamin Chen Dr. Benjamin Chen is the CEO and Chairman of Immune Targeting Systems (ITS), a company in the field of Immunology which is dedicating to creating vaccines for viral infections. During his career Dr. Chen has worked as a scientist, banker and entrepreneur. In addition to his duties at ITS he…

Michael Gibbons

The Servant Leader | Michael Gibbons

  About Michael Gibbons Michael Gibbons is the director of student support and an adjunct instructor of family and child development at Southern Virginia University. He has held that position since August of 2003 and also teaches courses in family and child development and in social and behavioral sciences. His BS degree is in developmental…